Drug Type Small molecule drug |
Synonyms CUO246 |
Mechanism Bacterial DNA gyrase inhibitors, Bacterial top IV inhibitors(Bacterial topoisomerase IV inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
COVID-19 | Preclinical | - | 21 Dec 2022 | |
Diagnostic agents | Preclinical | - | 01 Dec 2022 | |
Schizophrenia | Preclinical | - | 01 Dec 2022 | |
Respiratory Tract Infections | Preclinical | US | 30 Nov 2022 | |
Sexually Transmitted Diseases, Bacterial | Preclinical | US | 30 Nov 2022 | |
Skin and skin structure infections | Preclinical | US | 30 Nov 2022 |